These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7786236)

  • 21. Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.
    Lasker BA; Elie CM; Lott TJ; Espinel-Ingroff A; Gallagher L; Kuykendall RJ; Kellum ME; Pruitt WR; Warnock DW; Rimland D; McNeil MM; Reiss E
    Med Mycol; 2001 Aug; 39(4):341-52. PubMed ID: 11556764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.
    Diaz-Guerra TM; Martinez-Suarez JV; Laguna F; Valencia E; Rodriguez-Tudela JL
    AIDS; 1998 Sep; 12(13):1601-10. PubMed ID: 9764778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Candida albicans isolates from the oral cavity of HIV-positive patients.
    Woldeamanuel Y; Abate D
    Ethiop Med J; 1998 Oct; 36(4):235-43. PubMed ID: 11957299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode.
    Vargas K; Messer SA; Pfaller M; Lockhart SR; Stapleton JT; Hellstein J; Soll DR
    J Clin Microbiol; 2000 Oct; 38(10):3595-607. PubMed ID: 11015370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of four molecular typing methods for evaluating genetic diversity among Candida albicans isolates from human immunodeficiency virus-positive patients with oral candidiasis.
    Díaz-Guerra TM; Martínez-Suárez JV; Laguna F; Rodríguez-Tudela JL
    J Clin Microbiol; 1997 Apr; 35(4):856-61. PubMed ID: 9157142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients.
    Sullivan D; Bennett D; Henman M; Harwood P; Flint S; Mulcahy F; Shanley D; Coleman D
    J Clin Microbiol; 1993 Aug; 31(8):2124-33. PubMed ID: 8103773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.
    Sullivan DJ; Westerneng TJ; Haynes KA; Bennett DE; Coleman DC
    Microbiology (Reading); 1995 Jul; 141 ( Pt 7)():1507-21. PubMed ID: 7551019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
    Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
    J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequences type analysis of Candida albicans isolates from Iranian human immunodeficiency virus infected patients with oral candidiasis.
    Katiraee F; Khalaj V; Khosravi AR; Hajiabdolbaghi M
    Acta Med Iran; 2014; 52(3):187-91. PubMed ID: 24901719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection and pathogenicity of Candida albicans in HIV infection.
    Sweet SP
    Oral Dis; 1997 May; 3 Suppl 1():S88-95. PubMed ID: 9456665
    [No Abstract]   [Full Text] [Related]  

  • 34. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.
    Martins MD; Lozano-Chiu M; Rex JH
    Clin Infect Dis; 1998 Nov; 27(5):1291-4. PubMed ID: 9827284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users.
    Boerlin P; Boerlin-Petzold F; Durussel C; Addo M; Pagani JL; Chave JP; Bille J
    J Clin Microbiol; 1995 May; 33(5):1129-35. PubMed ID: 7615716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Candida albicans: the relationship between morphotypes and in-vitro adhesivity to the oral mucosa cells of HIV-positive and AIDS patients. I].
    Malighetti V; Arosio M; Bellotti MG; Spadari E; Zambellini Artini M; Spadari F; Riviera L
    Minerva Stomatol; 1998 Sep; 47(9):351-9. PubMed ID: 9835741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous carriage of Candida albicans strains from HIV-infected patients with oral candidiasis: multilocus enzyme electrophoresis analysis.
    Reynes J; Pujol C; Moreau C; Mallié M; Renaud F; Janbon F; Bastide JM
    FEMS Microbiol Lett; 1996 Apr; 137(2-3):269-73. PubMed ID: 8998997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting the adherence of Candida albicans to human buccal epithelial cells in human immunodeficiency virus infection.
    Tsang CS; Samaranayake LP
    Br J Dermatol; 1999 Nov; 141(5):852-8. PubMed ID: 10583166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals.
    Miyasaki SH; Hicks JB; Greenspan D; Polacheck I; MacPhail LA; White TC; Agabian N; Greenspan JS
    J Acquir Immune Defic Syndr (1988); 1992 Oct; 5(10):1039-46. PubMed ID: 1453319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates.
    Pizzo G; Barchiesi F; Falconi Di Francesco L; Giuliana G; Arzeni D; Milici ME; D'Angelo M; Scalise G
    Arch Oral Biol; 2002 Mar; 47(3):189-96. PubMed ID: 11839354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.